Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
Fuji
McKesson
US Department of Justice
Cipla
US Army
Chinese Patent Office
Accenture
Deloitte

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,747,896

« Back to Dashboard

Which drugs does patent 8,747,896 protect, and when does it expire?

Patent 8,747,896 protects SITAVIG and is included in one NDA.

This patent has twenty-six patent family members in twenty-four countries.
Summary for Patent: 8,747,896
Title:Mucosal bioadhesive slow release carrier for delivering active principles
Abstract: A mucosal bioadhesive slow release carrier comprising an active principle and devoid of starch, lactose, which can release the active principal for a duration of longer than 20 hours. This bioadhesive carrier contains a diluent, an alkali metal alkylsulfate, a binding agent, at least one bioadhesive polymer and at least one sustained release polymer, as well as a method for its preparation.
Inventor(s): Costantini; Dominique (Paris, FR), Lemarchand; Caroline (Paris, FR)
Assignee: BioAlliance Pharma (Paris, FR)
Application Number:13/565,653
Patent Claim Types:
see list of patent claims
Formulation; Delivery; Use;

Drugs Protected by US Patent 8,747,896

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Epi Hlth SITAVIG acyclovir TABLET;BUCCAL 203791-001 Apr 12, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y TREATMENT OF HERPES LABIALIS ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,747,896

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
06290480Mar 24, 2006

Non-Orange Book US Patents Family Members for Patent 8,747,896

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,211,466 Mucosal bioadhesive slow release carrier for delivering active principles ➤ Try a Free Trial
8,791,127 Mucosal bioadhesive slow release carrier for delivering active principles ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,747,896

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 101410092 ➤ Try a Free Trial
Cyprus 1109723 ➤ Try a Free Trial
Germany 602007002996 ➤ Try a Free Trial
Denmark 1998750 ➤ Try a Free Trial
European Patent Office 1837020 ➤ Try a Free Trial
European Patent Office 1998750 ➤ Try a Free Trial
European Patent Office 2216017 ➤ Try a Free Trial
Spain 2335712 ➤ Try a Free Trial
Hong Kong 1121692 ➤ Try a Free Trial
Croatia P20100039 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cerilliant
McKesson
Colorcon
Chinese Patent Office
Fish and Richardson
Queensland Health
US Army
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot